Search Results for "Pharmacovigilance Conference"

20:05 EDT 21st October 2014 | BioPortfolio

Matching Channels

BioPortfolio - life science, medical devices and pharmaceutical conference

BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.

Management Forum - highest quality conference, seminar and knowledge-based experiences

Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...

Matching News

Oviya MedSafe And Assured Information Systems Partner To Provide Comprehensive Pharmacovigilance Solutions To Pharmaceutical Companies

Indian pharmacovigilance consulting and drug safety services company Oviya MedSafe Pvt Ltd has signed an agreement with British software development company Assured Information Systems Ltd to combine ...

Extending the Scope of Pharmacovigilance Comes at a Price

As the pharmacovigilance infrastructure becomes more entrenched in Europe, drug manufacturers are beginning to feel the burden of its high cost.

Download: A successful path to fulfilling Pharmacovigilance obligations

  As the number of innovator pharmaceutical and generic manufacturer partnerships grow, the lines of responsibility for meeting pharmacovigilance requirements can get blurred. This whitepaper ...

EMA guideline on pharmacovigilance inspections comes into effect

As the EMA has announced that the main objectives of its pharmacovigilance legislation are largely being achieved , the agency is still implementing a number of the individual modules that make up the...

Download: Proactive Pharmacovigilance – A New Model for the 21st Century

Whitepaper courtesy of Sciformix 21st century technologies will create significant opportunities and challenges for all health care stakeholders. Pharmacovigilance too is in transition, with new sourc...

Highlights from EMA Pharmacovigilance October meeting

At its October meeting, the European Medicines Agency’ Pharmacovigilance Risk Assessment Committee (PRAC) concluded three safety reviews.

Promoting Drug Safety through Latest Advancements in Pharmacovigilance

OMICS Group is delighted to announce the 3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials on October 27-29, 2014 at Hyderabad India, with the theme "Safer Dr...

EMA updates requirements for pharmacovigilance legislation

The European Medicines Agency requires marketing-authorization holders to update the information on authorized medicines that they have submitted in accordance with Article 57(2) of the 2010 pharmacov...

Matching PubMed Articles

Need for involving consumers in Nepal's pharmacovigilance system.

In Nepal, reporting of adverse drug reactions (ADRs) occurs on a voluntary basis by doctors, pharmacists, nurses, health assistants, and other healthcare professionals. The country's pharmacovigilance...

Beriate(®) P in the treatment of patients with haemophilia A: Results of a long-term pharmacovigilance study.

The German Beriate(®) P pharmacovigilance study started in 2003 and is planned to run until December 2013.

Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study.

In India, the pharmacovigilance program is still in its infancy. National Pharmacovigilance Program of India was started for facilitating the pharmacovigilance activities. The ADR reporting rate is st...

Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.

In this report, we review the importance of pharmacovigilance in detecting postmarketing adverse drug events and the potential for developing pharmacogenovigilance programs by integrating pharmacogeno...

The supervisors' conference.

Since 1985, approximately 75% of the psychiatry department faculty of a medical school have met every two weeks for a supervisors' conference. The conference was conceived by members of the Residency ...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement